2-YEAR OUTCOMES OF LEADLESS VS. TRANSVENOUS SINGLE CHAMBER VENTRICULAR PACEMAKER IN HIGH-RISK SUBGROUPS
| Autor: | Boveda, S., Higuera, L., Longacre, C., Wolff, C., Stromberg, K., Wherry, K., Kamath, A., El-Chami, M. |
|---|---|
| Zdroj: | In Canadian Journal of Diabetes November 2023 47(7) Supplement:S22-S22 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect